1. Home
  2. News & Press
  3. GeneSight Mental Health Monitor: Special Election Series Phase III Update

GeneSight Mental Health Monitor: Special Election Series Phase III Update

News & Press
The latest installment of the GeneSight® Mental Health Monitor: Special Election Series, shows that as Election Day draws closer, Americans’ anxiety and/or depression around the 2024 Presidential Election remains significantly elevated.

The nationwide survey from Myriad Genetics, Inc, conducted in September 2024, is the final in a three-part series tracking how the election season is affecting American’s mental health, particularly amidst the ongoing mental health crisis in the United States.

Anxiety and/or depression around the election was already elevated during Phase I of the survey in May 2024, with 40% of Americans reporting feelings of depression and/or anxiety about the upcoming election. These levels have stayed elevated, with 45% feeling anxious or depressed in July, and 41% reporting similar feelings in September.

Additionally, of those who are already suffering from anxiety and/or depression, 50% reported feeling anxious and/or depressed about the election in May. Of the same population, 66% reported feeling anxious/depressed about the election in July, and 59% in September.

Phase III results of the survey also revealed that month-over-month depression and/or anxiety symptoms continue to worsen in the lead up to the election. As of September, those experiencing symptoms of anxiety and/or depression reported increased anxiety due to the news and social media around the election. In May, 49% reported increased anxiety, rising to 60% in July and just slightly decreased to 56% in September.

“It’s unfortunate that Americans’ mental health continues to be negatively affected by election season,” said Thomas J. Valente, M.D., a psychiatrist in Leesburg, Florida. “This multi-phase survey has showed that as campaigning ramped up, Americans’ mental health deteriorated. Given our country’s ongoing mental health crisis, this is a cause for concern.”

For individuals struggling with their mental health, the GeneSight test could be a useful tool as it provides clinicians with information about how their genes may affect how they break down or respond to certain medications commonly prescribed to treat depression, anxiety, and other mental health conditions.

“We hope that Americans will consider taking steps to improve their mental health given this important election is right around the corner,” said Valente. “The GeneSight test is one of the tools I’ve used to help my patients get back on the road to mental wellness.”

About the GeneSight Mental Health Monitor

The GeneSight Mental Health Monitor is a nationwide survey conducted online by ACUPOLL Precision Research, Inc. Phase I was conducted between May 8-15, 2024, Phase II was conducted between July 23-30, 2024, and Phase III was conducted between September 16-23, 2024 among a representative sample (n=1000) of U.S. adults age 18+. The margin of error in survey results for the total base population at a 95% confidence interval is +/- 3%. A nationally representative sample of adults aged 18 years or older was recruited and balanced to match U.S. Census quotas across five primary metrics (i.e., age, gender, income, region, ethnicity).

In addition to the nationally representative sample, a statistically reliable sample was desired of respondents who were self-reported as being diagnosed by a medical professional with depression or anxiety. The study also used mental health screening instruments, the Patient Health Questionnaire-2 (PHQ-2) for depression, and the General Anxiety Disorder (GAD-2) for anxiety, to better understand this population.

ACUPOLL has more than 30 years of experience conducting statistically valid research through careful recruiting and quality control measures.

Healthcare Provider

PRIME Care Time-to-Event Analysis

In 2022, the United States Department of Veterans Affairs (VA) undertook the Precision Medicine in Mental Health Care, or PRIME Care study, the largest phar...

Read more

    Learn more

    Learn more about GeneSight
    How to talk to your provider
    View our clinical studies

    Take the next step with the GeneSight test

    Take a step closer to getting the GeneSight test or registering to provide the test to your patients. We will follow up with additional information either via email or phone.

    The GeneSight test must be ordered by a registered clinician. If you are a patient, caregiver or office staff who would like a clinician to be registered to administer the GeneSight test, please include their name and contact information.

    If you are a current registered provider or tested patient, please contact us.

    Take the Next Step - PD

    1. Step 1
    2. Step 2
    3. Step 3
    Please provide us with your name



    1. Step 1
    2. Step 2
    3. Step 3
    Please provide contact and clinic information
    Please provide contact information

    We are asking for Date of Birth for data verification purposes.










    We are asking for Date of Birth for data verification purposes.

    If you do not have a clinician, we have a directory of healthcare providers who are registered to order the GeneSight test. When you complete this form, we will link you to this directory, so you will have the option to view registered GeneSight providers in your area.







    Your clinician who is currently managing your medication and making treatment decisions can order your GeneSight test.

    If you do not have a clinician, we have a directory of healthcare providers who are registered to order the GeneSight test. When you complete this form, we will link you to this directory, so you will have the option to view registered GeneSight providers in your area.

    Please provide your clinician's information
    The GeneSight test must be ordered by your clinician








    1. Step 1
    2. Step 2
    3. Step 3

    How can we help?
    When completed, we'll follow up with more information
    Please let us know how we can best help you
    When completed, we'll follow up with more information


    Already taken the GeneSight test and need access to your results?








    Contact Information

    By submitting this form, you authorize Myriad to contact you about your inquiry via email and/or phone (including SMS/text message). Additionally, please note communications may be unsecure and carry typical risks associated with such transmissions. By submitting this form, you also acknowledge that you understand the foregoing warning and understand the typical risk of email and phone transmissions. For further information on our privacy practices, including information about opting-out of communications for Myriad, please visit our Privacy Notice and Notice of Privacy Practices.

    Chat